These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 4032285)

  • 1. Phencyclidine (PCP) disposition kinetics in dogs as a function of dose and route of administration.
    Woodworth JR; Owens SM; Mayersohn M
    J Pharmacol Exp Ther; 1985 Sep; 234(3):654-61. PubMed ID: 4032285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disposition kinetics of the monohydroxy metabolites of phencyclidine in the dog.
    Woodworth JR; Mayersohn M; Owens SM
    J Pharmacol Exp Ther; 1986 Sep; 238(3):900-4. PubMed ID: 3746667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phencyclidine disposition in humans after small doses of radiolabeled drug.
    Cook CE; Perez-Reyes M; Jeffcoat AR; Brine DR
    Fed Proc; 1983 Jun; 42(9):2566-9. PubMed ID: 6852275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phencyclidine-specific Fab fragments alter phencyclidine disposition in dogs.
    Owens SM; Mayersohn M
    Drug Metab Dispos; 1986; 14(1):52-8. PubMed ID: 2868866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and disposition of the oxytocin receptor antagonist L-368,899 in rats and dogs.
    Thompson KL; Vincent SH; Miller RR; Colletti AE; Alvaro RF; Wallace MA; Feeney WP; Chiu SH
    Drug Metab Dispos; 1997 Oct; 25(10):1113-8. PubMed ID: 9321512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disposition of a monoclonal anti-phencyclidine Fab fragment of immunoglobulin G in rats.
    McClurkan MB; Valentine JL; Arnold L; Owens SM
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1439-45. PubMed ID: 8371148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-phencyclidine monoclonal Fab fragments markedly alter phencyclidine pharmacokinetics in rats.
    Valentine JL; Arnold LW; Owens SM
    J Pharmacol Exp Ther; 1994 Jun; 269(3):1079-85. PubMed ID: 8014850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absorption, disposition, and metabolism of trans-methyl styryl ketone in female B6C3F1 mice.
    Sauer JM; Bao J; Smith RL; Kuester RK; Mayersohn M; Sipes IG
    Drug Metab Dispos; 1997 Oct; 25(10):1184-90. PubMed ID: 9321522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral and topical absorption, disposition kinetics, and the metabolic fate of trans-methyl styryl ketone in the male Fischer 344 rat.
    Sauer JM; Smith RL; Bao J; Kattnig MJ; Kuester RK; McClure TD; Mayersohn M; Sipes IG
    Drug Metab Dispos; 1997 Jun; 25(6):732-9. PubMed ID: 9193875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disposition and metabolism of finasteride in dogs.
    Carlin JR; Christofalo P; Arison BH; Ellsworth RE; Rosegay A; Miller RR; Chiu SH; VandenHeuvel WJ
    Drug Metab Dispos; 1997 Jan; 25(1):100-9. PubMed ID: 9010636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term disposition of phencyclidine in mice.
    Martin BR
    Drug Metab Dispos; 1982; 10(2):189-93. PubMed ID: 6124408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phencyclidine disposition after intravenous and oral doses.
    Cook CE; Brine DR; Jeffcoat AR; Hill JM; Wall ME; Perez-Reyes M; Di Guiseppi SR
    Clin Pharmacol Ther; 1982 May; 31(5):625-34. PubMed ID: 7075111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absorption, disposition, and metabolism of [14C]didanosine in the beagle dog.
    Kaul S; Shyu WC; Shukla UA; Dandekar KA; Barbhaiya RH
    Drug Metab Dispos; 1993; 21(3):447-53. PubMed ID: 8100500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pharmacokinetics of [3H]1-[1-(2-thienyl)cyclohexyl]piperidine (TCP) in Sprague-Dawley rats.
    Zorbas M; Owens SM; Plunkett LM; Bui H
    Drug Metab Dispos; 1989; 17(6):641-5. PubMed ID: 2575500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of N-nitrosodimethylamine in beagles.
    Gombar CT; Pylypiw HM; Harrington GW
    Cancer Res; 1987 Jan; 47(2):343-7. PubMed ID: 3791224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and disposition of L-692,429. A novel nonpeptidyl growth hormone secretagogue in preclinical species.
    Leung KH; Cohn DA; Miller RR; Doss GA; Stearns RA; Simpson RE; Feeney WP; Chiu SH
    Drug Metab Dispos; 1996 Jul; 24(7):753-60. PubMed ID: 8818572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and metabolism of tesaglitazar, a novel dual-acting peroxisome proliferator-activated receptor alpha/gamma agonist, after a single oral and intravenous dose in humans.
    Ericsson H; Hamrén B; Bergstrand S; Elebring M; Fryklund L; Heijer M; Ohman KP
    Drug Metab Dispos; 2004 Sep; 32(9):923-9. PubMed ID: 15319332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of two and three compartment models of phencyclidine in man.
    Domino SE; Domino LE; Domino EF
    Subst Alcohol Actions Misuse; 1982; 3(4):205-11. PubMed ID: 7167862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and pharmacodynamics of the acetylcholinesterase inhibitor 2,2,2-trifluoro-1-(3-trimethylsilylphenyl) ethanone in dog. Potential for transdermal patch delivery.
    Dow J; Dulery BD; Hornsperger JM; Di Francesco GF; Keshary P; Haegele KD
    Arzneimittelforschung; 1995 Dec; 45(12):1245-52. PubMed ID: 8595078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absorption, disposition kinetics, and metabolic pathways of cyclohexene oxide in the male Fischer 344 rat and female B6C3F1 mouse.
    Sauer JM; Bao J; Smith RL; McClure TD; Mayersohn M; Pillai U; Cunningham ML; Sipes IG
    Drug Metab Dispos; 1997 Mar; 25(3):371-8. PubMed ID: 9172957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.